Ceryvyn Therapeutics Ltd Ceryvyn Therapeutics Ltd

Ceryvyn Therapeutics Ltd

OPT

Kedudukan dalam Saham #31867
Opthea Limited is an Australian clinical-stage biopharmaceutical company... Opthea Limited is an Australian clinical-stage biopharmaceutical company focused on developing and commercializing therapies primarily for eye diseases. The foundation of its development efforts lies in its intellectual property portfolio, which targets Vascular Endothelial Growth Factors (VEGF-C, VEGF-D, and VEGF Receptor-3). This technology is designed to address conditions linked to the growth of blood and lymphatic vessels, as well as vascular leakage. The company's leading asset, OPT 302, is a soluble form of VEGFR3 currently undergoing clinical trials. This novel therapy aims to treat wet neovascular age-related macular degeneration (wet AMD) and diabetic macular edema (DME). OPT 302 is distinguished as a first-in-class VEGF-C/D inhibitor, intended to be used in conjunction with VEGF-A inhibitors for the treatment of wet AMD and various other retinal diseases. Originally incorporated in 1984 as Circadian Technologies Limited, the company rebranded to Opthea Limited in December 2015 and is headquartered in South Yarra, Australia.
Harga Saham
$0.00846342
Disegerakkan terakhir: 2026-07-27
Modal Pasaran
$11.27M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-99.75%
Negara
AU
Perdagangan Ceryvyn Therapeutics Ltd (OPT)

Kategori

Healthcare
Sejarah pecahan saham untuk Ceryvyn Therapeutics Ltd (OPT)
Saham Ceryvyn Therapeutics Ltd (simbol: OPT) telah mengalami sejumlah 2 pecahan saham.
Pecahan saham terkini berlaku pada Oct 16, 2020.
Satu saham OPT yang dibeli sebelum Sep 13, 2016 kini bersamaan dengan 0.638125 saham OPT.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
2020-10-16 5:8 x0.625 x0.638125
2016-09-13 1021:1000 x1.021 x1.021
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL